Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 131 entries
View as:

A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01672476 Org: User:
Start: 04/30/12 End: 04/30/13 Due: 04/30/14

An Observational Study to Analyze the Prescription Pattern of Sugammadex and Its Effectiveness and Safety

Phase: N/A Priority: Normal
NCT ID: NCT05788718 Org: User:
Start: 04/11/23 End: 06/30/25 Due: 06/30/26

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-3" and "BR1019-2" in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06636877 Org: User:
Start: 10/23/24 End: 12/11/24 Due: 12/11/25

Observational Study to Evaluate the Safety and Efficacy of Zepzelca™ Injection

Phase: N/A Priority: Normal
NCT ID: NCT06021483 Org: User:
Start: 08/16/23 End: 09/30/25 Due: 09/30/26

A Clinical Study to Evaluate the Pharmacokinetics of Lozanoc and Sporanox in Korean Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02493738 Org: User:
Start: 07/31/15 End: 10/31/15 Due: 10/31/16

A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis Patients

Phase: N/A Priority: Normal
NCT ID: NCT01499368 Org: User:
Start: 11/30/11 End: 11/30/12 Due: 11/30/13

A Study to Evaluate the Pharmacokinetic, Pharmacodynamic Characteristics and the Safety After Administration by Doses of BR1400-1, BR1400-2, BR1400-3 in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06889064 Org: User:
Start: 09/24/24 End: 10/08/24 Due: 10/08/25

A Study to Evaluate the Pharmacokinetics After Administration of BR3003 and Co-administration of BR3003B and BR3003C.

Phase: N/A Priority: Normal
NCT ID: NCT05411965 Org: User:
Start: 04/28/22 End: 07/03/22 Due: 07/03/23

Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS

Phase: N/A Priority: Normal
NCT ID: NCT02458183 Org: User:
Start: 02/02/15 End: 05/05/18 Due: 05/05/19

Fimasartan (BR-A-657) Multiple Oral Dose in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01289899 Org: User:
Start: 01/31/04 End: 02/29/04 Due: 02/28/05

Clinical Study to Evaluate the Antihypertensive Efficacy and Changes of Neurohormonal Markers of Fimasartan and Atenolol With Exaggerated Blood Pressure Response During Exercise in Essential Hypertensive Patients

Phase: N/A Priority: Normal
NCT ID: NCT01736488 Org: User:
Start: 10/31/12 End: - Due: -

To Evaluate the Pharmacokinetic Interactions and Safety Between Fimasartan and Rosuvastatin

Phase: N/A Priority: Normal
NCT ID: NCT01921946 Org: User:
Start: 08/31/13 End: 10/31/13 Due: 10/31/14

A Multi Doses Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04857047 Org: User:
Start: 03/31/21 End: 06/28/21 Due: 06/28/22

A Clinical Trial to Compare the Pharmacokinetics and Bioequivalence of "BR2008" With "BR2008-1" in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05068193 Org: User:
Start: 09/06/21 End: 01/06/22 Due: 01/06/23

A Randomized, Double-blind, Active Control, Parallel Group, Titration, Multicenter Study to Evaluate the Efficacy and Safety of Fimasartan

Phase: N/A Priority: Normal
NCT ID: NCT02620306 Org: User:
Start: 02/11/16 End: 05/11/22 Due: 05/11/23

A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of "BR3005" and Co-administration of "BR3005-1" and "BR3005-2" Under Fed Conditions in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06289933 Org: User:
Start: 03/05/24 End: 04/03/24 Due: 04/03/25

Fimasartan in the Senior Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03246555 Org: User:
Start: 07/15/16 End: 12/09/19 Due: 12/09/20

A Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapy

Phase: N/A Priority: Normal
NCT ID: NCT01258673 Org: User:
Start: 11/30/10 End: - Due: -

Combination of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03629067 Org: User:
Start: 09/13/18 End: 12/27/18 Due: 12/27/19

Study to Evaluate the Pharmacokinetic Interaction Between Fimasartan and Atorvastatin in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02397590 Org: User:
Start: 03/31/15 End: 06/30/15 Due: 06/30/16

To Evaluate the Pharmacokinetics and Safety of Oral Administration of BR9001 Compared With BR900A in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03718611 Org: User:
Start: 10/22/18 End: 05/17/19 Due: 05/17/20

A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide

Phase: N/A Priority: Normal
NCT ID: NCT02222480 Org: User:
Start: 10/31/14 End: 06/30/15 Due: 06/30/16

A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Linagliptin in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03609294 Org: User:
Start: 07/18/18 End: 06/30/19 Due: 06/30/20

Long-term Immunogenicity and Safety of Fourth Administration of Boryung Cell-Culture Japanese Encephalitis Vaccineinj

Phase: N/A Priority: Normal
NCT ID: NCT02532569 Org: User:
Start: 08/31/15 End: 10/31/16 Due: 10/31/17

A Study to Evaluate Drug-drug Interactions Between BR9006-1 and BR9006-2 in Healthy Male Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT04485585 Org: User:
Start: 07/20/20 End: 08/26/20 Due: 08/26/21